<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Sat, 04 Apr 2026 09:58:09 -0400--><rss version="2.0">
    <channel>
        <title>Atara Biotherapeutics (ATRA) SEC Filings</title>
        <link>https://investors.atarabio.com/sec-filings/annual-reports/rss</link>
        <description>Atara Biotherapeutics (ATRA) - Annual Reports</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/atarabio/files/theme/images/logo-sm.png</url>
                <title>Atara Biotherapeutics Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]></title>
                <description><![CDATA[9 Related Documents: 10-K, EX-4.8, EX-19.1, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1, EX-97.1]]></description>
                <link>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001193125-26-108361/0001193125-26-108361.pdf</link>
                <pubDate>Mon, 16 Mar 26 16:16:19 -0400</pubDate>
                <guid>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001193125-26-108361/0001193125-26-108361.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]></title>
                <description><![CDATA[9 Related Documents: 10-K, EX-4.6, EX-19.1, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1, EX-97.1]]></description>
                <link>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0000950170-25-035507/0000950170-25-035507.pdf</link>
                <pubDate>Fri, 07 Mar 25 16:11:02 -0500</pubDate>
                <guid>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0000950170-25-035507/0000950170-25-035507.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[10 Related Documents: 10-K, EX-10.29, EX-10.30, EX-10.31, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1, EX-97.1]]></description>
                <link>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0000950170-24-037644/0000950170-24-037644.pdf</link>
                <pubDate>Thu, 28 Mar 24 08:41:55 -0400</pubDate>
                <guid>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0000950170-24-037644/0000950170-24-037644.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[7 Related Documents: 10-K, EX-10.46, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0000950170-23-002185/0000950170-23-002185.pdf</link>
                <pubDate>Wed, 08 Feb 23 16:55:52 -0500</pubDate>
                <guid>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0000950170-23-002185/0000950170-23-002185.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[11 Related Documents: 10-K, EX-10.35, EX-10.36, EX-10.37, EX-10.38, EX-10.39, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001564590-22-007633/0001564590-22-007633.pdf</link>
                <pubDate>Mon, 28 Feb 22 17:00:02 -0500</pubDate>
                <guid>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001564590-22-007633/0001564590-22-007633.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[7 Related Documents: 10-K, EX-10.30, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001564590-21-009854/0001564590-21-009854.pdf</link>
                <pubDate>Mon, 01 Mar 21 17:06:39 -0500</pubDate>
                <guid>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001564590-21-009854/0001564590-21-009854.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[12 Related Documents: 10-K, EX-1.1, EX-4.4, EX-5.1, EX-10.22, EX-10.23, EX-10.24, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001564590-20-007027/0001564590-20-007027.pdf</link>
                <pubDate>Thu, 27 Feb 20 07:48:26 -0500</pubDate>
                <guid>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001564590-20-007027/0001564590-20-007027.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[9 Related Documents: 10-K, EX-1.1, EX-5.1, EX-10.14, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001564590-19-004275/0001564590-19-004275.pdf</link>
                <pubDate>Tue, 26 Feb 19 08:49:18 -0500</pubDate>
                <guid>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001564590-19-004275/0001564590-19-004275.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[6 Related Documents: 10-K, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001564590-18-003390/0001564590-18-003390.pdf</link>
                <pubDate>Fri, 02 Nov 18 17:19:25 -0400</pubDate>
                <guid>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001564590-18-003390/0001564590-18-003390.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]></title>
                <description><![CDATA[7 Related Documents: 10-K, EX-10.21, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001564590-17-003792/0001564590-17-003792.pdf</link>
                <pubDate>Fri, 02 Nov 18 17:18:23 -0400</pubDate>
                <guid>https://investors.atarabio.com/sec-filings/all-sec-filings/content/0001564590-17-003792/0001564590-17-003792.pdf</guid>
                                                                            </item>
            </channel>
</rss>